Cargando…

Inhibition of ATR protein kinase activity by schisandrin B in DNA damage response

ATM and ATR protein kinases play a crucial role in cellular DNA damage responses. The inhibition of ATM and ATR can lead to the abolition of the function of cell cycle checkpoints. In this regard, it is expected that checkpoint inhibitors can serve as sensitizing agents for anti-cancer chemo/radioth...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishida, Hiroshi, Tatewaki, Naoto, Nakajima, Yuki, Magara, Taku, Ko, Kam Ming, Hamamori, Yasuo, Konishi, Tetsuya
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2761266/
https://www.ncbi.nlm.nih.gov/pubmed/19625493
http://dx.doi.org/10.1093/nar/gkp593
_version_ 1782172817395023872
author Nishida, Hiroshi
Tatewaki, Naoto
Nakajima, Yuki
Magara, Taku
Ko, Kam Ming
Hamamori, Yasuo
Konishi, Tetsuya
author_facet Nishida, Hiroshi
Tatewaki, Naoto
Nakajima, Yuki
Magara, Taku
Ko, Kam Ming
Hamamori, Yasuo
Konishi, Tetsuya
author_sort Nishida, Hiroshi
collection PubMed
description ATM and ATR protein kinases play a crucial role in cellular DNA damage responses. The inhibition of ATM and ATR can lead to the abolition of the function of cell cycle checkpoints. In this regard, it is expected that checkpoint inhibitors can serve as sensitizing agents for anti-cancer chemo/radiotherapy. Although several ATM inhibitors have been reported, there are no ATR-specific inhibitors currently available. Here, we report the inhibitory effect of schisandrin B (SchB), an active ingredient of Fructus schisandrae, on ATR activity in DNA damage response. SchB treatment significantly decreased the viability of A549 adenocarcinoma cells after UV exposure. Importantly, SchB treatment inhibited both the phosphorylation levels of ATM and ATR substrates, as well as the activity of the G2/M checkpoint in UV-exposed cells. The protein kinase activity of immunoaffinity-purified ATR was dose-dependently decreased by SchB in vitro (IC(50): 7.25 μM), but the inhibitory effect was not observed in ATM, Chk1, PI3K, DNA-PK, and mTOR. The extent of UV-induced phosphorylation of p53 and Chk1 was markedly reduced by SchB in ATM-deficient but not siATR-treated cells. Taken together, our demonstration of the ability of SchB to inhibit ATR protein kinase activity following DNA damage in cells has clinical implications in anti-cancer therapy.
format Text
id pubmed-2761266
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-27612662009-10-14 Inhibition of ATR protein kinase activity by schisandrin B in DNA damage response Nishida, Hiroshi Tatewaki, Naoto Nakajima, Yuki Magara, Taku Ko, Kam Ming Hamamori, Yasuo Konishi, Tetsuya Nucleic Acids Res Genome Integrity, Repair and Replication ATM and ATR protein kinases play a crucial role in cellular DNA damage responses. The inhibition of ATM and ATR can lead to the abolition of the function of cell cycle checkpoints. In this regard, it is expected that checkpoint inhibitors can serve as sensitizing agents for anti-cancer chemo/radiotherapy. Although several ATM inhibitors have been reported, there are no ATR-specific inhibitors currently available. Here, we report the inhibitory effect of schisandrin B (SchB), an active ingredient of Fructus schisandrae, on ATR activity in DNA damage response. SchB treatment significantly decreased the viability of A549 adenocarcinoma cells after UV exposure. Importantly, SchB treatment inhibited both the phosphorylation levels of ATM and ATR substrates, as well as the activity of the G2/M checkpoint in UV-exposed cells. The protein kinase activity of immunoaffinity-purified ATR was dose-dependently decreased by SchB in vitro (IC(50): 7.25 μM), but the inhibitory effect was not observed in ATM, Chk1, PI3K, DNA-PK, and mTOR. The extent of UV-induced phosphorylation of p53 and Chk1 was markedly reduced by SchB in ATM-deficient but not siATR-treated cells. Taken together, our demonstration of the ability of SchB to inhibit ATR protein kinase activity following DNA damage in cells has clinical implications in anti-cancer therapy. Oxford University Press 2009-09 2009-07-22 /pmc/articles/PMC2761266/ /pubmed/19625493 http://dx.doi.org/10.1093/nar/gkp593 Text en © 2009 The Author(s) http://creativecommons.org/licenses/by-nc/2.0/uk/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Genome Integrity, Repair and Replication
Nishida, Hiroshi
Tatewaki, Naoto
Nakajima, Yuki
Magara, Taku
Ko, Kam Ming
Hamamori, Yasuo
Konishi, Tetsuya
Inhibition of ATR protein kinase activity by schisandrin B in DNA damage response
title Inhibition of ATR protein kinase activity by schisandrin B in DNA damage response
title_full Inhibition of ATR protein kinase activity by schisandrin B in DNA damage response
title_fullStr Inhibition of ATR protein kinase activity by schisandrin B in DNA damage response
title_full_unstemmed Inhibition of ATR protein kinase activity by schisandrin B in DNA damage response
title_short Inhibition of ATR protein kinase activity by schisandrin B in DNA damage response
title_sort inhibition of atr protein kinase activity by schisandrin b in dna damage response
topic Genome Integrity, Repair and Replication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2761266/
https://www.ncbi.nlm.nih.gov/pubmed/19625493
http://dx.doi.org/10.1093/nar/gkp593
work_keys_str_mv AT nishidahiroshi inhibitionofatrproteinkinaseactivitybyschisandrinbindnadamageresponse
AT tatewakinaoto inhibitionofatrproteinkinaseactivitybyschisandrinbindnadamageresponse
AT nakajimayuki inhibitionofatrproteinkinaseactivitybyschisandrinbindnadamageresponse
AT magarataku inhibitionofatrproteinkinaseactivitybyschisandrinbindnadamageresponse
AT kokamming inhibitionofatrproteinkinaseactivitybyschisandrinbindnadamageresponse
AT hamamoriyasuo inhibitionofatrproteinkinaseactivitybyschisandrinbindnadamageresponse
AT konishitetsuya inhibitionofatrproteinkinaseactivitybyschisandrinbindnadamageresponse